Carolina at Chapel Hill. He is also an investigator in the UNC Gene Therapy Center and Carolina Institute for Developmental Disabilities. He was previously a Post Doc at UNC and before that had undertaken a PhD in Molecular Biology, at Vanderbilt University. His core expertise is in AAV gene therapy vector engineering, followed by optimizing approaches to deliver a gene to the nervous system or eye.